glucagon has been researched along with Weight Loss in 97 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.09) | 18.7374 |
| 1990's | 18 (18.56) | 18.2507 |
| 2000's | 23 (23.71) | 29.6817 |
| 2010's | 34 (35.05) | 24.3611 |
| 2020's | 19 (19.59) | 2.80 |
| Authors | Studies |
|---|---|
| Bloom, SR; Hinds, CE; Hope, DCD; Jones, B; Minnion, JS; Owen, BM; Pickford, P; Tan, TM | 1 |
| Dornonville de la Cour, C; Guo, T; Jeppesen, JF; Kruse, T; Lau, J; McGuire, J; Niss, K; Raun, K; Sauerberg, P; Simonsen, L | 1 |
| Conceição-Furber, E; Coskun, T; Samms, RJ; Sloop, KW | 1 |
| Horowitz, M; Jalleh, RJ; Jones, KL; Rayner, CK | 1 |
| Abernathy, M; Benson, C; Briere, DA; Coskun, T; Du, Y; Gimeno, RE; Haupt, A; Loghin, C; Milicevic, Z; Morford, L; Moyers, JS; O'Farrell, LS; Pirro, V; Qu, H; Roell, WC; Sloop, KW; Thomas, MK; Urva, S; Wainscott, DB; Willard, FS | 1 |
| Bloom, SR; Carling, D; Davies, I; Hinds, CE; Hope, DCD; Jones, B; Lopes, T; Lutz, TA; Minnion, JS; Murphy, KG; Owen, BM; Sardini, A; Scott, R; Shrewsbury, JV; Tan, TMM; Vincent, ML; Yu, ATC | 1 |
| Hope, DCD; Tan, TM | 1 |
| Frikke-Schmidt, R; Holst, JJ; Janus, C; Jensen, SBK; Juhl, CR; Knudsen, C; Lundgren, JR; Madsbad, S; Martinussen, C; Stallknecht, BM; Torekov, SS; Wiingaard, C | 1 |
| Ambery, P; Iqbal, N; Logue, J; Mallappa, A; Sjöström, CD | 1 |
| Bloom, S; Carling, D; Davies, I; Dore, M; Goldin, R; Hope, DCD; Khoo, B; Le Gall, M; McGlone, ER; Owen, B; Siebert, M; Tan, TM | 1 |
| Argyrakopoulou, G; Bontozoglou, N; Kalra, B; Kokkinos, A; Konstantinidou, SK; Kouvari, M; Kumar, A; Kumar, M; Kyriakopoulou, K; Mantzoros, CS; Simati, S; Stefanakis, K | 1 |
| Baek, S; Byeon, J; Choi, J; Hompesch, M; Kang, S; Shin, W | 1 |
| Endahl, L; Friedrichsen, MH; Goldwater, R; Kankam, M; Kreiner, FF; Nygård, SB; Toubro, S | 1 |
| Blaslov, K; Kruljac, I; Rahelić, D; Renar, IP; Režić, T; Vrkljan, M | 1 |
| Brooks, A; Guyton, J; Jeon, M | 1 |
| Avraham, Y; Bi, X; Cai, X; Dai, Y; He, L; Huang, W; Li, C; Liu, C; Qian, H; Sun, L; Tong, J; Wang, Y; Zhou, J | 1 |
| Boujan, N; Géraud, C | 1 |
| Pei, Z; Wang, S; Yan, J; Yang, X; Zhou, D | 1 |
| Bahekar, R; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, M; Patel, V; Savsani, H | 1 |
| Antipenko, J; Cunningham, SE; DiMarchi, R; Finan, B; Gamble, KL; Habegger, KM; Holleman, C; Hunter, CS; Kharitonenkov, A; Kim, T; Nason, SR; Paul, JR; Pierre, TH; Presedo, N; Young, ME | 1 |
| Ardévol, A; Beltrán-Debón, R; Blay, M; Grau-Bové, C; Miguéns-Gómez, A; Pinent, M; Rodríguez-Gallego, E; Sierra-Cruz, M; Terra, X | 1 |
| Goode, JP; McMahon, C; Poppitt, SD; Silvestre, MP; Tay, A; Vlaskovsky, P | 1 |
| Charron, MJ; Drucker, DJ; Matthews, D; Patel, A; Seeley, RJ; Yusta, B | 1 |
| Cabrera, A; Del Castillo, D; Molina, A; París, M; Raga, E; Sabench, F; Sánchez, A; Vives, M | 1 |
| Kra, G; Levin, Y; Livshitz, L; Moallem, U; Nemirovski, A; Tam, J; Udi, S; Zachut, M | 1 |
| Gao, Z; Lee, S; Qiu, P; Wang, C; Williams, DB; Yang, J; Zhou, X | 1 |
| Andersen, MM; Bergmann, NC; Bergmann, S; Christensen, MB; Gasbjerg, LS; Hartmann, B; Holst, JJ; Jessen, L; Knop, FK; Lund, A; Meessen, ECE; Vilsbøll, T | 1 |
| Andersson, T; Chorell, E; Holst, JJ; Larsson, C; Lindahl, B; Mellberg, C; Olsson, T; Otten, J; Ryberg, M | 1 |
| Bloom, SR; Bouvy, ND; Buurman, WA; de Jonge, C; Greve, JW; le Roux, CW; Rensen, SS; Schaper, NC; Verdam, FJ; Vincent, RP | 1 |
| Anselmino, M; Astiarraga, B; Baldi, S; Camastra, S; Ciociaro, D; Ferrannini, E; Gastaldelli, A; Holst, JJ; Mari, A; Muscelli, E; Nannipieri, M | 1 |
| Auerbach, P; Gram, AS; Holst, JJ; Ploug, T; Reichkendler, MH; Rosenkilde, M; Sjödin, A; Stallknecht, B; Toräng, S | 1 |
| Chabenne, J; Clemmensen, C; Dimarchi, R; Finan, B; Fischer, K; Hofmann, SM; Küchler, D; Müller, TD; Ograjsek, T; Pfluger, PT; Pinkstaff, J; Schriever, SC; Sehrer, L; Sullivan, L; Tschöp, MH | 1 |
| Pellitero, S; Puig-Domingo, M | 1 |
| Baretić, M; Troskot, R | 1 |
| Almokayyad, RM; Gannon, MC; Nuttall, FQ | 1 |
| Adin, CA; Borin-Crivellenti, S; Gilor, C; Hall, MJ; Lakritz, J; Rajala-Schultz, P; Rudinsky, AJ | 1 |
| Bojsen-Møller, KN | 1 |
| Ahmed, L; Bantle, JP; Bessler, M; Billington, CJ; Connett, JE; Ikramuddin, S; Inabnet, WB; Korner, J; Nguyen, KT; Thomas, A; Vella, A; Wang, Q | 1 |
| Fischer, M; Hauber, M; Jarick, I; Krepak, Y; Lee-Barkey, YH; Schiffer, E; Stratmann, B; Tschoepe, D | 1 |
| Bartoszewicz, Z; Grodzicki, M; Kalinowski, P; Krawczyk, M; Paluszkiewicz, R; Remiszewski, P; Wróblewski, T | 1 |
| Wang, N; Wang, X; Xing, XY; Yang, WY; Yang, ZJ; Zhang, B; Zhang, JP | 1 |
| Bianchi, C; Gentilella, R; Rossi, A; Rotella, CM | 1 |
| Bodenner, DL; Coker, RH; Evans, WJ; Kern, PA; Kortebein, PM; Williams, RH; Yeo, SE | 1 |
| Kliewer, SA; Mangelsdorf, DJ | 1 |
| Adeghate, E; Donáth, T; Hameed, RS; Ponery, AS; Shaffiullah, M; Sheen, RS; Tariq, S | 1 |
| Arias, S; Bawa, B; Bose, M; Laferrère, B; Machineni, S; Olivan, B; Pi-Sunyer, FX; Scherer, PE; Teixeira, J | 1 |
| Campbell, RK; Cobble, ME; Reid, TS; Shomali, ME | 1 |
| Andreelli, F; Batterham, RL; Chandarana, K; Choudhury, AI; Drew, ME; Fauveau, V; Gelegen, C; Karra, E; Viollet, B; Withers, DJ | 1 |
| Cuenca Cuenca, JI; Guerrero Vázquez, R; Navarro González, E; Oliva Rodríguez, R; Sánchez Alberdi, F | 1 |
| Sandoval, DA; Tong, J | 1 |
| Arasaki, CH; Carneiro, G; Geloneze, B; Silva, EA; Umeda, LM; Zanella, MT | 1 |
| Fernández-Real, JM; Frühbeck, G; Moreno-Navarrete, JM; Ortega, FJ; Ricart, W; Sabater, M | 1 |
| Almdal, T; Bojsen-Møller, KN; Clausen, TR; Dirksen, C; Hansen, DL; Holst, JJ; Hvolris, LE; Jacobsen, SH; Jørgensen, NB; Kielgast, U; Madsbad, S; Naver, LS; Olesen, SC; Rehfeld, JF; Worm, D; Wulff, BS | 1 |
| Bianchi, E; Cao, J; Carrington, PE; Chicchi, GG; Hubert, J; Kosinski, JR; Marsh, DJ; Miller, C; Mu, J; Pessi, A; Pocai, A; Sinharoy, R | 1 |
| Aeberli, I; Berneis, K; Erb, A; Finlayson, GS; Fox, M; Frühauf, H; Gassmann, M; Götze, O; Langhans, W; Lutz, TA; Maggiorini, M; Meier, D; Spliethoff, K | 1 |
| Cahoy, JD; Heit, JJ; Hori, Y; Kim, SK; Rulifson, IC; Tsai, BC | 1 |
| Adamson, U; Ahrén, B; Guldstrand, M | 1 |
| Adamson, U; Ahrén, B; Backman, L; Guldstrand, M; Lins, PE; Wredling, R | 1 |
| Barilli, AL; Camellini, C; Dei Cas, A; Ganzerla, GC; Gnudi, A; Luciani, A; Lugari, R; Mittenperger, F; Nodari, S; Salerni, B; Ugolotti, D; Zandomeneghi, R | 1 |
| Adner, N; Gutniak, M; Hellström, PM; Holst, JJ; King, N; Mansten, S; Näslund, E | 1 |
| Balci, H; Damci, T; Ilkova, H; Korugan, U; Osar, Z; Ozyazar, M; Yalin, S | 1 |
| D'Alessio, DA; Jandacek, RJ; Seeley, RJ; Strader, AD; Vahl, TP; Woods, SC | 1 |
| Adam, TC; Westerterp-Plantenga, MS | 1 |
| Lozano, O; Malaisse, WJ; Martín-Duce, A; Molina, L; Puente, J; Sancho, V; Valverde, I; Villanueva-Peñacarrillo, ML | 1 |
| Ballantyne, GH; Gumbs, AA; Modlin, IM | 1 |
| Champagne, CD; Crocker, DE; Houser, DS | 1 |
| Djurhuus, CB; Gjedsted, J; Gormsen, LC; Keiding, S; Møller, N; Nielsen, S; Schmitz, O; Tønnesen, E; Ørskov, H | 1 |
| Akana, SF; Dallman, MF; de Jong, HK; Foster, MT; Ginsberg, AB; Horneman, HF; Pecoraro, NC; Warne, JP | 1 |
| Banks, MR; Klein, S; Patterson, BW; Polonsky, KS; Villareal, DT | 1 |
| Bawa, B; Colarusso, A; Egger, JR; Koshy, N; Kovack, B; Laferrère, B; Lee, H; McGinty, J; Olivan, B; Teixeira, J; Tran, H; Yapp, K | 1 |
| Aaboe, K; Holst, JJ; Krarup, T; Madsbad, S | 1 |
| Anderson, BL; Barbieri, TF; Keim, NL; Wu, MM | 1 |
| Colzi, G; Cresci, B; Galli, G; Giannini, S; Mannucci, E; Messeri, G; Piani, F; Rizzello, SM; Rotella, CM; Vannini, R | 1 |
| Inoue, S; Numata, K; Saito, M; Shishido, T; Tanaka, K | 1 |
| Holst, JJ; Karlsen, C; Kofod, H; Larsson, LI; Lund, K; Madsen, OD; Nielsen, E; Rehfeld, JF; Steiner, DF; Welinder, B | 1 |
| Bading, JR; Brennan, MF; Conlon, KC; Corbally, MT; McDermott, EW; Tolvo, AJ | 1 |
| Haymond, MW; Jensen, MD; Kanaley, JA | 1 |
| Böhm, J; Büchler, MW; Friess, H; Glasbrenner, B; Malfertheiner, P; Müller, MW; Riepl, RL | 1 |
| Grossman, EB; Gumbiner, B; Low, CC | 1 |
| Henry, JG; Inzucchi, SE; Kinder, BK; Xue, N | 1 |
| McCarty, MF | 2 |
| Elahi, D; Ryan, AS | 1 |
| Blume, N; Holst, JJ; Jensen, HI; Jensen, PB; Larsen, PJ; Madsen, OD; Mikkelsen, JD | 1 |
| Backman, L; Hellström, PM; Holst, JJ; Näslund, E; Theodorsson, E | 1 |
| Dagnelie, PC; Hordijk-Luijk, CH; Leij-Halfwerk, S; van Den Berg, JW; Wattimena, JD; Wilson, JP | 1 |
| Dagnelie, PC; Leij-Halfwerk, S; Oudkerk, M; Sijens, PE; van den Berg, JW; Wilson, JH | 1 |
| Bihain, BE; Ebbets-Reed, D; Erickson, MR; Fruebis, J; Javorschi, S; Lodish, HF; Tsao, TS; Yen, FT | 1 |
| Astrup, A; Buemann, B; Juul Holst, J; Lysgård Madsen, J; Toubro, S; Verdich, C | 1 |
| Djuricin, G; Gattuso, P; Kouris, GJ; Liu, Q; Nathan, C; Prinz, RA; Rossi, H; Weinstein, RA | 1 |
| al-Sheibani, S; Knapp, ML; Riches, PG | 1 |
| Andersen, T; Astrup, A; Breum, L; Bülow, J; Christensen, NJ; Madsen, J; Quaade, F | 1 |
| Gage, D; Geliebter, A; Hashim, SA; McCray, RS; Melton, PM | 1 |
| Almdal, T; Heindorff, H; Vilstrup, H | 1 |
| Cymerman, A; Green, HJ; Houston, CS; Rose, MS; Sutton, JR; Young, PM | 1 |
| Almdal, TP; Vilstrup, H; Wanscher, B | 1 |
| Asano, T; Kan, K; Ninomiya, H; Okumura, M; Yamamoto, T | 1 |
12 review(s) available for glucagon and Weight Loss
| Article | Year |
|---|---|
Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
Topics: Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Obesity; Receptors, Glucagon; Weight Loss | 2022 |
Glucagon and energy expenditure; Revisiting amino acid metabolism and implications for weight loss therapy.
Topics: Amino Acids; Energy Metabolism; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Obesity; Receptors, Glucagon; Weight Loss | 2023 |
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Exenatide; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Liraglutide; Treatment Outcome; Weight Loss | 2019 |
The role of glucagon in weight loss-mediated metabolic improvement: a systematic review and meta-analysis.
Topics: Bariatric Surgery; Blood Glucose; Diet, Reducing; Fasting; Glucagon; Humans; Insulin Resistance; Obesity; Observational Studies as Topic; Weight Loss | 2018 |
[New therapies for type 2 diabetes mellitus].
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Dipeptidyl Peptidase 4; Drug Therapy, Combination; Drugs, Investigational; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucokinase; Gluconeogenesis; Glucose; Humans; Hypoglycemic Agents; Incretins; Insulin Resistance; Insulin, Long-Acting; Molecular Targeted Therapy; Obesity; Phosphofructokinase-2; Sodium-Glucose Transport Proteins; Weight Loss | 2015 |
How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Topics: Anti-Obesity Agents; Bariatric Surgery; Biological Transport; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycosuria; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Kidney Tubules, Proximal; Microvilli; Multicenter Studies as Topic; Obesity; Peptides; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Venoms; Weight Loss | 2015 |
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Topics: Anastomosis, Roux-en-Y; Blood Glucose; Body Mass Index; Denmark; Female; Follow-Up Studies; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Obesity, Morbid; Quality of Life; Treatment Outcome; Weight Loss | 2015 |
Exenatide: a review from pharmacology to clinical practice.
Topics: Blood Glucose; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Exenatide; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Peptides; Randomized Controlled Trials as Topic; Venoms; Weight Loss | 2009 |
Fibroblast growth factor 21: from pharmacology to physiology.
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Fibroblast Growth Factors; Glucagon; Growth Substances; Humans; Insulin; Liver; Mice; Obesity; Pancreas; Primates; Rodentia; Starvation; Triglycerides; Weight Loss | 2010 |
Is the GLP-1 system a viable therapeutic target for weight reduction?
Topics: Animals; Body Weight; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Weight Loss | 2011 |
Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Caloric Restriction; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Male; Obesity, Morbid; Peptide Fragments; Peptide Hormones; Prognosis; Protein Precursors; Treatment Outcome; Weight Loss | 2005 |
GLP-1: physiological effects and potential therapeutic applications.
Topics: Animals; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Islets of Langerhans; Receptors, Glucagon; Satiety Response; Weight Loss | 2008 |
20 trial(s) available for glucagon and Weight Loss
| Article | Year |
|---|---|
Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Glucagon; Glucose; Humans; Hypoglycemic Agents; Liraglutide; Weight Loss | 2023 |
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Glucagon; Humans; Hypertension; Hypoglycemic Agents; Morbidity; Obesity; Overweight; Weight Loss | 2023 |
Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity.
Topics: Adult; Blood Glucose; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Obesity; Overweight; Weight Loss | 2023 |
Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
Topics: Adult; Bariatric Surgery; Biomarkers; Blood Glucose; Body Mass Index; Fasting; Female; Gastrectomy; Gastric Bypass; Gastrointestinal Hormones; Glucagon; Humans; Insulin; Laparoscopy; Male; Obesity, Morbid; Pancreatic Hormones; Prospective Studies; Weight Loss | 2018 |
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
Topics: Adult; Aged; Appetite; Blood Glucose; Calorimetry; Cross-Over Studies; Double-Blind Method; Energy Intake; Energy Metabolism; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Obesity; Overweight; Weight Loss | 2019 |
Postprandial levels of GLP-1, GIP and glucagon after 2 years of weight loss with a Paleolithic diet: a randomised controlled trial in healthy obese women.
Topics: Aged; Biomarkers; Diet, Paleolithic; Energy Intake; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Middle Aged; Obesity; Postprandial Period; Weight Loss | 2019 |
Appetite regulation in overweight, sedentary men after different amounts of endurance exercise: a randomized controlled trial.
Topics: Adult; Appetite; Appetite Regulation; Blood Glucose; Energy Intake; Exercise; Fasting; Fatty Acids, Nonesterified; Ghrelin; Glucagon; Glycerol; Humans; Insulin; Male; Overweight; Peptide Fragments; Peptide YY; Postprandial Period; Sedentary Behavior; Weight Loss; Young Adult | 2013 |
Comparison of a carbohydrate-free diet vs. fasting on plasma glucose, insulin and glucagon in type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Caloric Restriction; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Restricted; Diet, Reducing; Fasting; Glucagon; Hospitals, Veterans; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Weight Loss | 2015 |
Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Topics: Adiponectin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Treatment Outcome; Weight Loss | 2015 |
Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Female; Gastrectomy; Gastric Bypass; Ghrelin; Glucagon; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Laparoscopy; Leptin; Male; Middle Aged; Obesity, Morbid; Operative Time; Prospective Studies; Weight Loss; Young Adult | 2017 |
The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in obesity.
Topics: Aged; Aged, 80 and over; Body Weight; Caloric Restriction; Exercise; Gas Chromatography-Mass Spectrometry; Glucagon; Humans; Insulin; Insulin Resistance; Liver; Middle Aged; Obesity; Overweight; Patient Selection; Weight Loss | 2009 |
Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies; Treatment Outcome; Weight Loss | 2011 |
Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
Topics: Adult; Biliopancreatic Diversion; Dipeptidyl Peptidase 4; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Obesity, Morbid; Peptide Fragments; Postoperative Period; Protein Precursors; Weight Loss | 2004 |
Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Eating; Feeding Behavior; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Hunger; Infusions, Parenteral; Injections, Subcutaneous; Male; Middle Aged; Nausea; Obesity; Peptide Fragments; Protein Precursors; Recombinant Proteins; Satiation; Thirst; Weight Loss | 2004 |
Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients.
Topics: Adult; Aged; Anti-Obesity Agents; Cross-Over Studies; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Lactones; Male; Middle Aged; Obesity; Orlistat; Peptide Fragments; Protein Precursors; Single-Blind Method; Weight Loss | 2004 |
Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.
Topics: Adipose Tissue; Adult; Arm; Calorimetry, Indirect; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Isotope Labeling; Leg; Lipid Metabolism; Lipolysis; Male; Microdialysis; Muscle, Skeletal; Palmitates; Subcutaneous Fat; Subcutaneous Fat, Abdominal; Weight Loss | 2007 |
Weight loss therapy improves pancreatic endocrine function in obese older adults.
Topics: Aged; Aging; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Obesity; Risk Factors; Weight Loss | 2008 |
Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
Topics: Analysis of Variance; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Monounsaturated; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity; Time Factors; Triglycerides; Weight Loss | 1996 |
Weight loss and elevated gluconeogenesis from alanine in lung cancer patients.
Topics: Aged; Alanine; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Cross-Sectional Studies; Deuterium; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Lung Neoplasms; Male; Middle Aged; Weight Loss | 2000 |
Gastric balloon to treat obesity: a double-blind study in nondieting subjects.
Topics: Adult; Double-Blind Method; Eating; Female; Gastric Balloon; Gastric Emptying; Glucagon; Glucose; Humans; Insulin; Male; Obesity; Time Factors; Weight Loss | 1990 |
65 other study(ies) available for glucagon and Weight Loss
| Article | Year |
|---|---|
A glucagon analogue decreases body weight in mice via signalling in the liver.
Topics: Animals; Anti-Obesity Agents; Biological Variation, Population; Dose-Response Relationship, Drug; Female; Glucagon; HEK293 Cells; Hepatocytes; Humans; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Rats, Wistar; Receptors, Glucagon; Signal Transduction; Weight Loss | 2021 |
Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls.
Topics: Animals; Blood Glucose; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Mice; Mice, Obese; Obesity; Rats; Receptors, Glucagon; Weight Loss | 2022 |
Glucagon-like peptide-1 receptor agonists, weight loss, and gastric emptying: have I gut news for you.
Topics: Blood Glucose; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Peptide Fragments; Weight Loss | 2022 |
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.
Topics: Animals; Body Weight; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide-1 Receptor; Glycemic Control; Mice; Mice, Obese; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Weight Loss | 2022 |
Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss.
Topics: Amino Acids; Animals; Energy Metabolism; Glucagon; Mice; Mice, Obese; Receptors, Glucagon; Weight Loss | 2022 |
Perspectives in weight control in diabetes - SGLT2 inhibitors and GLP-1-glucagon dual agonism.
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss | 2023 |
Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis.
Topics: Animals; Blood Glucose; Fatty Liver; Gastrectomy; Glucagon; Mice; Obesity; Weight Loss | 2023 |
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long
Topics: Bupropion; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Humans; Liraglutide; Naltrexone; Obesity; Overweight; Peptides; Proglucagon; Weight Loss | 2023 |
The possible synergistic action of sex hormones and glucagon-like peptide-1 (GLP-1) agonists on body mass decline in patients with type 2 diabetes mellitus.
Topics: Adiposity; Anti-Obesity Agents; Appetite Depressants; Diabetes Mellitus, Type 2; Drug Synergism; Estradiol; Female; Glucagon; Glucagon-Like Peptide 1; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Insulin; Male; Menstrual Cycle; Models, Biological; Overweight; Pancreas; Risk Factors; Secretory Rate; Testosterone; Weight Loss | 2019 |
Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties.
Topics: Amino Acid Sequence; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Energy Intake; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Hypoglycemic Agents; Mice; Obesity; Oxyntomodulin; Peptides; Sequence Homology, Amino Acid; Streptozocin; Structure-Activity Relationship; Weight Loss | 2020 |
Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
Topics: Glucagon; Glucagonoma; Humans; Male; Middle Aged; Necrolytic Migratory Erythema; Neoplasm Invasiveness; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Rare Diseases; Recovery of Function; Risk Assessment; Syndrome; Treatment Outcome; Weight Loss | 2020 |
Design and characterization of novel oxyntomodulin derivatives with potent dual GLP-1/glucagon receptor activation and prolonged antidiabetic effects.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Dimerization; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Hypoglycemic Agents; Macaca fascicularis; Male; Mice; Mice, Knockout; Mice, Obese; Obesity; Oxyntomodulin; Polyethylene Glycols; Rats, Sprague-Dawley; Receptors, Glucagon; Solid-Phase Synthesis Techniques; Weight Loss | 2020 |
Combination of Lorcaserin and GLP-1/glucagon Coagonist Improves Metabolic Dysfunction in Diet Induced-obese Mice.
Topics: Animals; Benzazepines; Body Weight; Diet, High-Fat; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Liver; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Glucagon; Weight Loss | 2020 |
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes.
Topics: Animals; Body Weight; Eating; Fibroblast Growth Factors; Gene Expression; Glucagon; Glucose; Homeostasis; Klotho Proteins; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Peptides; Receptors, Glucagon; Signal Transduction; Weight Loss | 2021 |
Grape-Seed Proanthocyanidin Extract Reverts Obesity-Related Metabolic Derangements in Aged Female Rats.
Topics: Adiposity; Animals; Blood Glucose; Disease Models, Animal; Fatty Liver; Female; Glucagon; Grape Seed Extract; Insulin; Obesity; Proanthocyanidins; Rats; Rats, Wistar; Weight Loss | 2021 |
GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Topics: Animals; Bile Acids and Salts; Blood Glucose; Body Weight; Diet, High-Fat; Gastrectomy; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptide-2 Receptor; Glucose; Glucose Tolerance Test; Homeostasis; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Proglucagon; Receptors, G-Protein-Coupled; Receptors, Glucagon; Signal Transduction; Weight Loss | 2018 |
Gastric Plication and Sleeve Gastrectomy in an Experimental Model of Obesity: New Insights into Weight Loss, Intake and Metabolic Results.
Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Energy Intake; Gastrectomy; Ghrelin; Glucagon; Laparoscopy; Male; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; Stomach; Weight Loss | 2018 |
Characterization of the endocannabinoid system in subcutaneous adipose tissue in periparturient dairy cows and its association to metabolic profiles.
Topics: Animals; Blood Glucose; Cattle; Dairying; Diet; Endocannabinoids; Fatty Acids; Female; Glucagon; Insulin; Metabolome; Oxidative Stress; Postpartum Period; Pregnancy; Proteomics; RNA, Messenger; Subcutaneous Fat; Weight Loss | 2018 |
Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
Topics: Adolescent; Adult; Aged; Area Under Curve; Bariatric Surgery; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Duodenum; Eating; Endoscopy; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Jejunum; Male; Middle Aged; Netherlands; Obesity; Pilot Projects; Postprandial Period; Remission Induction; Time Factors; Treatment Outcome; Weight Loss | 2013 |
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gastric Bypass; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Obesity; Obesity, Morbid; Weight Loss | 2013 |
GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet.
Topics: Animals; Diet, High-Fat; Eating; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Polyethylene Glycols; Receptors, Glucagon; Weight Loss | 2014 |
Pharmacokinetics and pharmacodynamics of the glucagon-like peptide-1 analog liraglutide in healthy cats.
Topics: Animals; Appetite; Blood Glucose; Cats; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Weight Loss | 2015 |
Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
Topics: Adiposity; Adult; Aged; Bariatric Surgery; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Duodenum; Female; Follow-Up Studies; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Jejunum; Male; Middle Aged; Obesity, Morbid; Treatment Outcome; Weight Loss | 2016 |
Associations between changes in glucagon-like peptide-1 and bodyweight reduction in patients receiving acarbose or metformin treatment.
Topics: Acarbose; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Education as Topic; Weight Loss | 2017 |
Streptozotocin causes pancreatic beta cell failure via early and sustained biochemical and cellular alterations.
Topics: Animals; Cell Degranulation; Diabetes Mellitus, Experimental; Epinephrine; Glucagon; Hydroxyindoleacetic Acid; Hyperglycemia; In Vitro Techniques; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Norepinephrine; Osmolar Concentration; Pancreas; Rats; Rats, Wistar; Secretory Vesicles; Streptozocin; Time Factors; Weight Loss | 2010 |
Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Leptin; Middle Aged; Obesity, Morbid; Postoperative Period; Stomach; Weight Loss | 2010 |
Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies.
Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Liraglutide; Male; Metformin; Middle Aged; Peptides; Pyrazines; Receptors, Glucagon; Risk; Sitagliptin Phosphate; Triazoles; Venoms; Weight Loss | 2010 |
Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
Topics: Analysis of Variance; Animals; Colon; Diet, Fat-Restricted; Diet, Reducing; Enzyme-Linked Immunosorbent Assay; Gastric Bypass; Gastric Mucosa; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Leptin; Male; Mice; Obesity; Peptide YY; Radioimmunoassay; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Weight Loss | 2011 |
[Malignant glucagonoma: an uncommon cause of new onset diabetes].
Topics: Adult; Alopecia; Anemia; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Chromogranin A; Combined Modality Therapy; Diabetes Mellitus; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hyperglycemia; Necrolytic Migratory Erythema; Octreotide; Pancreatectomy; Pancreatic Neoplasms; Weight Loss | 2011 |
Circulating glucagon is associated with inflammatory mediators in metabolically compromised subjects.
Topics: Adult; Aged; Anthropometry; Body Mass Index; Cohort Studies; Complement Factor B; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Inflammation Mediators; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Metabolic Diseases; Middle Aged; Obesity; Triglycerides; Weight Loss | 2011 |
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Topics: Adult; Appetite; C-Peptide; Cholecystokinin; Confounding Factors, Epidemiologic; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Leptin; Male; Middle Aged; Obesity, Morbid; Pancreatic Polypeptide; Peptide YY; Postprandial Period; Somatostatin; Time Factors; Weight Loss | 2012 |
The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.
Topics: Animals; Anti-Obesity Agents; Energy Intake; Glucagon; Glucagon-Like Peptide-1 Receptor; Glycogenolysis; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Oxyntomodulin; Receptors, Glucagon; Weight Loss | 2012 |
Disturbed eating at high altitude: influence of food preferences, acute mountain sickness and satiation hormones.
Topics: Adult; Altitude; Altitude Sickness; Appetite; Body Mass Index; Cholecystokinin; Dexamethasone; Dipeptides; Eating; Energy Intake; Feeding Behavior; Female; Food Preferences; Gastrins; Glucagon; Humans; Hunger; Islet Amyloid Polypeptide; Male; Middle Aged; Satiation; Surveys and Questionnaires; Weight Loss; Young Adult | 2013 |
Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells.
Topics: Androstadienes; Animals; Biomarkers; Cell Aggregation; Cell Differentiation; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Embryo, Mammalian; Enzyme Inhibitors; Glucagon; Growth Inhibitors; Homeostasis; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms, Experimental; Niacinamide; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Stem Cell Transplantation; Stem Cells; Streptozocin; Weight Loss; Wortmannin | 2002 |
Improved beta-cell function after standardized weight reduction in severely obese subjects.
Topics: Adult; Body Composition; Female; Glucagon; Glucose Intolerance; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Obesity, Morbid; Proinsulin; Weight Loss | 2003 |
Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects.
Topics: Adrenal Glands; Adult; Autonomic Nervous System; Blood Pressure; Cognition; Epinephrine; Female; Gastroplasty; Glucagon; Glucose Clamp Technique; Homeostasis; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypothalamus; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Norepinephrine; Obesity, Morbid; Pancreatic Polypeptide; Pituitary Gland; Pulse; Weight Loss | 2003 |
Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.
Topics: Adaptation, Physiological; Animals; Bariatrics; Energy Intake; Feeding Behavior; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Ilium; Jejunum; Male; Peptide Fragments; Peptide YY; Protein Precursors; Rats; Rats, Long-Evans; Weight Loss | 2005 |
Activity-induced GLP-1 release in lean and obese subjects.
Topics: Adult; Analysis of Variance; Area Under Curve; Basal Metabolism; Blood Glucose; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Motor Activity; Obesity; Peptide Fragments; Protein Precursors; Thinness; Weight Loss | 2004 |
Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
Topics: Adipocytes; Adult; Age Factors; Bariatrics; Biliopancreatic Diversion; Blood Glucose; Cholesterol; Cholesterol, LDL; Female; Follow-Up Studies; Gastroplasty; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Lipolysis; Male; Obesity, Morbid; Peptide Fragments; Protein Precursors; Triglycerides; Weight Loss | 2005 |
Glucose metabolism during lactation in a fasting animal, the northern elephant seal.
Topics: Animals; Blood Glucose; Body Composition; Fasting; Female; Glucagon; Gluconeogenesis; Glucose; Hydrocortisone; Insulin; Lactation; Lactic Acid; Seals, Earless; Tritium; Weight Loss | 2006 |
The gastroduodenal branch of the common hepatic vagus regulates voluntary lard intake, fat deposition, and plasma metabolites in streptozotocin-diabetic rats.
Topics: Animals; Blood Glucose; Body Fat Distribution; Corticosterone; Diabetes Mellitus, Experimental; Dietary Fats; Eating; Fatty Acids; Gastric Inhibitory Polypeptide; Glucagon; Glycogen; Hypoglycemic Agents; Insulin; Liver; Male; Rats; Rats, Sprague-Dawley; Vagotomy; Vagus Nerve; Weight Loss | 2008 |
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Weight Loss | 2008 |
Moderate diet restriction alters the substrate and hormone response to exercise.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Body Composition; Carbohydrate Metabolism; Carbohydrates; Diet, Reducing; Energy Intake; Energy Metabolism; Exercise Therapy; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Heart Rate; Humans; Hydroxybutyrates; Insulin; Lipid Metabolism; Lipids; Obesity; Oxygen Consumption; Weight Loss | 1994 |
Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Energy Intake; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Receptor, Insulin; Weight Loss | 1994 |
Very low calorie diet-induced weight loss reverses exaggerated insulin secretion in response to glucose, arginine and glucagon in obesity.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Body Mass Index; C-Peptide; Energy Intake; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Kinetics; Male; Obesity; Weight Loss | 1993 |
The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha- and beta-cell tumor phenotypes.
Topics: Adenoma, Islet Cell; Animals; Anorexia; Base Sequence; Blotting, Northern; Cholecystokinin; Eating; Gastrins; Gene Expression; Glucagon; Hormones; Hypoglycemia; Molecular Sequence Data; Neoplasm Transplantation; Pancreatic Neoplasms; Protein Precursors; Rats; Tumor Cells, Cultured; Weight Loss | 1993 |
Extremity metabolism in the cachectic, VX-2 carcinoma-bearing rabbit.
Topics: Amino Acids; Animals; Blood Glucose; Cachexia; Calcium; Eating; Extremities; Glucagon; Hematopoiesis; Insulin; Lactates; Lactic Acid; Male; Muscles; Neoplasm Transplantation; Neoplasms, Experimental; Rabbits; Weight Loss | 1993 |
Effects of exercise and weight loss on leucine turnover in different types of obesity.
Topics: Adult; Body Composition; Body Mass Index; Epinephrine; Exercise; Female; Glucagon; Growth Hormone; Hormones; Humans; Hydrocortisone; Insulin; Leucine; Norepinephrine; Obesity; Weight Loss | 1993 |
Maldigestion after total gastrectomy is associated with pancreatic insufficiency.
Topics: Ceruletide; Cholecystokinin; Exocrine Pancreatic Insufficiency; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Malabsorption Syndromes; Male; Middle Aged; Pancreatic Function Tests; Pancreatic Polypeptide; Postgastrectomy Syndromes; Prospective Studies; Secretin; Time Factors; Weight Loss | 1996 |
A 73-year-old man with hyperglycemia, skin rashes, anemia and weight loss.
Topics: Aged; Anemia; Diagnosis, Differential; Erythema; Glucagon; Glucagonoma; Humans; Hyperglycemia; Male; Pancreatic Neoplasms; Tomography, X-Ray Computed; Weight Loss | 1996 |
Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control.
Topics: Chromium; Down-Regulation; gamma-Aminobutyric Acid; Glucagon; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Models, Biological; Weight Loss | 1996 |
The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral adiposity, and age in women.
Topics: Adipose Tissue; Adolescent; Adult; Age Factors; Aged; Diabetes Mellitus, Type 2; Exercise; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hyperinsulinism; Leptin; Middle Aged; Peptide Fragments; Protein Precursors; Proteins; Weight Loss | 1996 |
Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.
Topics: Animals; Anorexia; Arcuate Nucleus of Hypothalamus; Drinking; Female; Glucagon; Glucagon-Like Peptide 1; Glucagonoma; Male; Neoplasm Transplantation; Neuropeptide Y; Pancreatic Neoplasms; Peptide Fragments; Protein Precursors; Rats; RNA, Messenger; Weight Loss | 1998 |
Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity.
Topics: Adult; Blood Glucose; Body Mass Index; Case-Control Studies; Female; Follow-Up Studies; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Intestine, Small; Jejunoileal Bypass; Middle Aged; Peptide Fragments; Postprandial Period; Protein Precursors; Time Factors; Weight Loss | 1998 |
Altered hepatic gluconeogenesis during L-alanine infusion in weight-losing lung cancer patients as observed by phosphorus magnetic resonance spectroscopy and turnover measurements.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Carcinoma, Non-Small-Cell Lung; Female; Glucagon; Gluconeogenesis; Humans; Insulin; Liver; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Weight Loss | 2000 |
Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity.
Topics: Animals; Cardiovascular Diseases; China; Diet, Vegetarian; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Liver; Male; Neoplasms; Obesity; Plant Proteins, Dietary; Puberty; Risk Factors; Weight Loss | 1999 |
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.
Topics: Adipocytes; Adiponectin; Amino Acid Sequence; Animals; Blood Glucose; Blood Proteins; Endopeptidases; Fatty Acids; Glucagon; Humans; Insulin; Intercellular Signaling Peptides and Proteins; Leptin; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Muscle, Skeletal; Oxidation-Reduction; Protein Processing, Post-Translational; Proteins; Triglycerides; Weight Loss | 2001 |
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
Topics: Absorptiometry, Photon; Adult; Appetite; Area Under Curve; Energy Intake; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Satiation; Weight Loss | 2001 |
The effect of glucagon-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis.
Topics: Analysis of Variance; Animals; Bacterial Translocation; Glucagon; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Ileum; Intestinal Mucosa; Jejunum; Male; Pancreatitis, Acute Necrotizing; Peptides; Permeability; Rats; Rats, Sprague-Dawley; Weight Loss | 2001 |
Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors.
Topics: Alcohol Drinking; Bone Neoplasms; Breast Neoplasms; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fasting; Female; Glucagon; Hormones; Humans; Lipids; Smoking; Triglycerides; Tumor Necrosis Factor-alpha; Weight Loss | 1991 |
Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans.
Topics: Adult; Blood Glucose; Body Temperature Regulation; C-Peptide; Energy Metabolism; Epinephrine; Female; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Norepinephrine; Obesity; Sympathetic Nervous System; Weight Loss | 1990 |
Contradictory effects of uncomplicated versus complicated abdominal surgery on the hepatic capacity for urea synthesis in rats.
Topics: Amino Acids; Animals; Blood Glucose; Eating; Female; Galactosemias; Glucagon; Hysterectomy; Insulin; Ligation; Liver; Rats; Rats, Inbred Strains; Spleen; Stress, Physiological; Surgical Procedures, Operative; Urea; Uterus; Weight Loss | 1990 |
Operation Everest II: plasma lipid and hormonal responses during a simulated ascent of Mt. Everest.
Topics: Adult; Altitude; Blood Glucose; Body Composition; Fasting; Fatty Acids, Nonesterified; Glucagon; Glycerol; Growth Hormone; Hormones; Humans; Hypoxia; Insulin; Lipids; Male; Norepinephrine; Nutritional Status; Oxygen Consumption; Reference Values; Triglycerides; Weight Loss | 1989 |
Effects of adrenalectomy on urea synthesis in rats.
Topics: Adrenalectomy; Alanine; Animals; Blood Glucose; Fasting; Female; Glucagon; Glucocorticoids; Insulin; Rats; Rats, Inbred Strains; Urea; Weight Loss | 1989 |
Plasma glucagon response to intravenous alanine in obese and non-obese subjects.
Topics: Alanine; Fatty Acids; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Obesity; Weight Loss | 1989 |